249 related articles for article (PubMed ID: 8571424)
1. Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease.
Touho H; Karasawa J; Ohnishi H
Stroke; 1996 Feb; 27(2):282-9. PubMed ID: 8571424
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic evaluation of paraparetic transient ischaemic attacks in childhood moyamoya disease.
Touho H; Karasawa J; Ohnishi H
Neurol Res; 1995 Jun; 17(3):162-8. PubMed ID: 7643970
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic improvement of anterior cerebral artery territory perfusion induced by bifrontal encephalo(periosteal) synangiosis in pediatric patients with moyamoya disease: a study with brain perfusion SPECT.
Song YS; Oh SW; Kim YK; Kim SK; Wang KC; Lee DS
Ann Nucl Med; 2012 Jan; 26(1):47-57. PubMed ID: 22033781
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-HMPAO-SPECT with acetazolamide challenge to detect hemodynamic compromise in occlusive cerebrovascular disease.
Knop J; Thie A; Fuchs C; Siepmann G; Zeumer H
Stroke; 1992 Dec; 23(12):1733-42. PubMed ID: 1448823
[TBL] [Abstract][Full Text] [Related]
5. Cerebral vasodilatory capacity mapping using technetium-99m-DTPA-HSA SPECT and acetazolamide in moyamoya disease.
Inoue Y; Momose T; Machida K; Honda N; Tsutsumi K
J Nucl Med; 1993 Nov; 34(11):1984-6. PubMed ID: 8229245
[TBL] [Abstract][Full Text] [Related]
6. Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study.
Saito N; Nakagawara J; Nakamura H; Teramoto A
Ann Nucl Med; 2004 Jun; 18(4):323-31. PubMed ID: 15359926
[TBL] [Abstract][Full Text] [Related]
7. The scintigraphic appearance of childhood moyamoya disease on cerebral perfusion imaging.
Miller JH; Khonsary A; Raffel C
Pediatr Radiol; 1996 Dec; 26(12):833-8. PubMed ID: 8929293
[TBL] [Abstract][Full Text] [Related]
8. Moyamoya disease in twins.
Duman Y; Dirlik A; Burak Z; Tütüncü S
Clin Nucl Med; 1995 Sep; 20(9):810-2. PubMed ID: 8521659
[TBL] [Abstract][Full Text] [Related]
9. Time-course analysis of brain perfusion single photon emission computed tomography using a three-dimensional stereotactic region-of-interest template in patients with moyamoya disease.
Marushima A; Tsurushima H; Suzuki K; Nakai Y; Nemoto H; Matsumura A
World Neurosurg; 2011; 76(3-4):304-10. PubMed ID: 21986429
[TBL] [Abstract][Full Text] [Related]
10. Adaptive changes of autoregulation in chronic cerebral hypotension with arteriovenous malformations: an acetazolamide-enhanced single-photon emission CT study.
Hacein-Bey L; Nour R; Pile-Spellman J; Van Heertum R; Esser PD; Young WL
AJNR Am J Neuroradiol; 1995 Oct; 16(9):1865-74. PubMed ID: 8693988
[TBL] [Abstract][Full Text] [Related]
11. Increased brain retention of Tc-99m HMPAO following acetazolamide administration.
Burt RW; Witt RM; Cikrit D; Carter J
Clin Nucl Med; 1991 Aug; 16(8):568-71. PubMed ID: 1934809
[TBL] [Abstract][Full Text] [Related]
12. Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery.
So Y; Lee HY; Kim SK; Lee JS; Wang KC; Cho BK; Kang E; Lee DS
Stroke; 2005 Jul; 36(7):1485-9. PubMed ID: 15947261
[TBL] [Abstract][Full Text] [Related]
13. Effect of adenosine on cerebral blood flow as evaluated by single-photon emission computed tomography in normal subjects and in patients with occlusive carotid disease. A comparison with acetazolamide.
Soricelli A; Postiglione A; Cuocolo A; De Chiara S; Ruocco A; Brunetti A; Salvatore M; Ell PJ
Stroke; 1995 Sep; 26(9):1572-6. PubMed ID: 7660400
[TBL] [Abstract][Full Text] [Related]
14. [Cerebral perfusion reserve SPECT imaging before and during acetazolamide test using consecutive 99mTc-HMPAO SPECT].
Terada H; Gomi T; Furukawa T; Murakami S; Sato S; Nagamoto M; Sekiguchi R; Kuwajima A; Hiramatsu Y; Sakai T
Kaku Igaku; 1991 May; 28(5):509-15. PubMed ID: 1886285
[No Abstract] [Full Text] [Related]
15. [The usefulness of single photon emission computed tomography using N-isopropyl-p-[123I]-iodoamphetamine and 99mTc-hexamethylpropyleneamine oxime in patients with moyamoya disease].
Morita K; Ono S; Fukunaga M; Otsuka N; Nagai K; Furukawa T; Muranaka A; Mimura H; Yanagimoto S; Tomomitsu T
Kaku Igaku; 1990 Jan; 27(1):69-80. PubMed ID: 2338770
[No Abstract] [Full Text] [Related]
16. SPECT evaluation of brain perfusion reserve by the acetazolamide test using Tc-99m HMPAO.
Matsuda H; Higashi S; Kinuya K; Tsuji S; Nozaki J; Sumiya H; Hisada K; Yamashita J
Clin Nucl Med; 1991 Aug; 16(8):572-9. PubMed ID: 1934810
[TBL] [Abstract][Full Text] [Related]
17. Postoperative neurological deterioration in pediatric moyamoya disease: watershed shift and hyperperfusion.
Hayashi T; Shirane R; Fujimura M; Tominaga T
J Neurosurg Pediatr; 2010 Jul; 6(1):73-81. PubMed ID: 20593991
[TBL] [Abstract][Full Text] [Related]
18. Regional cerebral hemodynamics in childhood moyamoya disease.
Kuroda S; Houkin K; Kamiyama H; Abe H; Mitsumori K
Childs Nerv Syst; 1995 Oct; 11(10):584-90. PubMed ID: 8556725
[TBL] [Abstract][Full Text] [Related]
19. Brain Perfusion Imaging Under Acetazolamide Challenge for Detection of Impaired Cerebrovascular Reserve Capacity: Positive Findings with
Acker G; Lange C; Schatka I; Pfeifer A; Czabanka MA; Vajkoczy P; Buchert R
J Nucl Med; 2018 Feb; 59(2):294-298. PubMed ID: 28729429
[TBL] [Abstract][Full Text] [Related]
20. [Brain perfusion SPECT imaging before and during the acetazolamide test using 99mTc-HMPAO].
Matsuda H; Higashi S; Kinuya K; Tsuji S; Sumiya H; Hisada K; Yamashita J
Kaku Igaku; 1990 May; 27(5):485-92. PubMed ID: 2395232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
